Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$6.16 - $12.07 $187,325 - $367,048
-30,410 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$7.91 - $22.95 $240,543 - $697,909
30,410 New
30,410 $629,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Trustees Of Princeton University Portfolio

Follow Trustees Of Princeton University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Princeton University, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Princeton University with notifications on news.